Evaluation of two doses (20 mL and 15 mL) of 0.25% bupivacaine in pericapsular nerve group block for patient positioning for sub-arachnoid block during hip fracture surgery: A single-centre, randomised comparative trial
Anita Sharma, Shelly Rana, Bhanu Gupta, Aditi Ranaut, Rita Khanoria, Neha Bhardwaj- Anesthesiology and Pain Medicine
Background and Aims:
Peri-capsular nerve group (PENG) block is a novel ultrasound (US)-guided technique to achieve regional analgesia in hip fractures. We compared the effectiveness of two doses of 0.25% bupivacaine (20 mL and 15 mL) in the US-guided PENG block for positioning patients for sub-arachnoid block (SAB) during hip fracture surgery.
Methods:
The randomised trial included 60 patients aged 40–90 years undergoing hip fracture surgery under SAB. PENG block was given by a US-guided approach with the patient in a supine position 20 minutes before SAB, and a total of 20 mL and 15 mL of bupivacaine (0.25%) were given in groups A and B, respectively. The primary outcome was to measure and compare the ease of positioning (EOP) of patients for the conduct of SAB. The secondary outcome was the pain assessment at rest and 15° leg raise position at baseline and 10 and 20 minutes post block using the verbal analogue scale (VAS). Continuous variables were compared using the
Results:
The mean (standard deviation) grade of EOP for SAB was significantly better in group A (2.47 (0.73) (95% confidence interval [CI]: 2.19–2.69)) than in group B (1.86 (0.62) (95% CI: 1.65–2.1)) (
Conclusion:
A dose of 20 mL of 0.25% bupivacaine shows better outcomes than 15 mL regarding the patient’s positioning during the SAB.